News in the Life Sciences Industry | |
Results 381 - 400 out of 500 displayed. | |
« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 » |
Orexo´s Nomination Committee for the Annual General Meeting 2021 |
UPPSALA, Sweden, Oct. 13, 2020 /PRNewswire/ -- Prior to the Annual General Meeting (AGM) in 2021, Orexo has appointed a Nomination Committee which represents approximately 44 percent of the number of votes in the company as of September 30, 2020. Read more ›› |
By: PR Newswire Association LLC. - 13 Oct 2020 |
Related companies: Orexo AB |
Envirotainer Unleashes Free Shipment reports |
STOCKHOLM, Oct. 13, 2020 /PRNewswire/ -- Envirotainer, the global market leader and the by far largest provider of temperature-controlled air freight solutions for pharmaceuticals, today announced that they open up unlimited and free access to shipment data for all their customers. The shipment... Read more ›› |
By: PR Newswire Association LLC. - 13 Oct 2020 |
Related companies: Envirotainer AB |
Enzymatica and STADA extend agreement on ViruProtect to Russia, Poland, Ukraine and CIS countries |
Enzymatica has licensed to STADA exclusive rights to market and sell the common cold spray ViruProtect® (ColdZyme®) in Russia, Poland, Ukraine and 11 further countries in the CIS and Central Asia. |
By: PR Newswire Association LLC. - 13 Oct 2020 |
Related companies: Enzymatica AB |
AlzeCure gets abstract on the NeuroRestore platform against Alzheimer's accepted for poster presentation at CTAD |
STOCKHOLM, Oct. 13, 2020 /PRNewswire/ -- AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of drug candidates for diseases affecting the central nervous system, with projects in both Alzheimer's disease and pain, today announced... Read more ›› |
By: PR Newswire Association LLC. - 13 Oct 2020 |
Related companies: AlzeCure Pharma AB |
Dupixent® (dupilumab) significantly reduced severe asthma attacks in children and is the only biologic to demonstrate improvement in children’s lung function in a randomized Phase 3 trial |
Read more ›› |
By: GlobenewsWire - 13 Oct 2020 |
TFS Announces Partnership with the Duke Clinical Research Institute |
LUND, Sweden, Oct. 12, 2020 /PRNewswire/ -- TFS recently entered into a strategic partnership with the Duke Clinical Research Institute (DCRI) to provide data management solutions across the academic research organization's study portfolio. Read more ›› |
By: PR Newswire Association LLC. - 12 Oct 2020 |
Related companies: TFS Trial Form Support International AB | TFS International AB |
Novo Nordisk A/S – Share repurchase programme |
Read more ›› |
By: GlobenewsWire - 12 Oct 2020 |
With the priority review underway at FDA, Oncopeptides moves forward with intent to file for conditional approval of melflufen with EMA |
STOCKHOLM, Oct. 12, 2020 /PRNewswire/ -- Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO) today announces that the Company has informed the European Medicines Agency, EMA, about its intention to submit an application for a conditional marketing authorization of melflufen (INN melphalan flufenamide)... Read more ›› |
By: PR Newswire Association LLC. - 12 Oct 2020 |
Related companies: Oncopeptides AB |
The Covid-19 pandemic is expected to further affect RhoVac's clinical phase IIb study |
LUND, Sweden, Oct. 12, 2020 /PRNewswire/ -- RhoVac AB ("RhoVac") announces today that the company's clinical phase IIb study in prostate cancer, a multi-center study with the designation RhoVac-002 ("BRaVac"), is expected to be further delayed due to the prevailing Covid-19 pandemic. The... Read more ›› |
By: PR Newswire Association LLC. - 12 Oct 2020 |
Related companies: RhoVac AB |
Sobi announces topline phase 3 data of avatrombopag for the treatment of Chemotherapy-Induced Thrombocytopenia |
STOCKHOLM, Oct. 9, 2020 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi(TM)) (STO:SOBI) today announced topline results from its phase 3 study of avatrombopag, an oral thrombopoietin (TPO) receptor agonist, in solid tumour cancer patients with chemotherapy-induced thrombocytopenia (CIT).... Read more ›› |
By: PR Newswire Association LLC. - 09 Oct 2020 |
Related companies: Swedish Orphan Biovitrum AB (Sobi™) | Sobi |
Major Manufacturers Select TECHNIA's "Light My Way" Digital Adoption Solution for 3DEXPERIENCE |
STOCKHOLM, Oct. 9, 2020 /PRNewswire/ -- TECHNIA, the #1 knowledge leaders in PLM, announced today that two major OEMs - a Scandinavian leader in the residential property market and a USA supplier of inspection equipment to the semiconductor industry - are selecting "Light My Way" a TECHNIA... Read more ›› |
By: PR Newswire Association LLC. - 09 Oct 2020 |
SI-BONE Reports Preliminary Unaudited Revenue for the Third Quarter 2020 and Provides Full Year 2020 Revenue Guidance |
Read more ›› |
By: GlobenewsWire - 08 Oct 2020 |
Novo Nordisk raises sales and operating profit outlook for 2020 |
Read more ›› |
By: GlobenewsWire - 08 Oct 2020 |
Life-changing medical innovations that makes the impossible possible |
STOCKHOLM, Oct. 8, 2020 /PRNewswire/ -- Medical wire that stops the trembling caused by Parkinson's disease. Precision tools that can manufacture tailored prosthetic limbs durable and flexible enough to race down the slopes. And 3D-printing technologies that can create scull and spinal implants... Read more ›› |
By: PR Newswire Association LLC. - 08 Oct 2020 |
Oblique Therapeutics together with collaborators at Sahlgrenska University Hospital and Karolinska Institutet has been granted 5MSEK by Vinnova |
STOCKHOLM, Oct. 8, 2020 /PRNewswire/ -- Oblique Therapeutics AB together with collaborators at Sahlgrenska University Hospital (Gothenburg) and Karolinska Institutet (Stockholm) has been granted 5MSEK by Vinnova to develop neutralizing antibodies towards SARS-CoV-2 and to develop its Abiprot(TM)... Read more ›› |
By: PR Newswire Association LLC. - 08 Oct 2020 |
Related companies: Oblique Therapeutics AB |
Cantargia completes recruitment and reports positive interim update in CAN04 pancreatic cancer combination therapy |
STOCKHOLM, Oct. 8, 2020 /PRNewswire/ -- Cantargia AB today announced that all 31 pancreatic cancer (PDAC) patients planned in the CANFOUR trial investigating combination of CAN04 and chemotherapy have started treatment. In the interim data set, no unexpected side effects have been reported,... Read more ›› |
By: PR Newswire Association LLC. - 08 Oct 2020 |
Related companies: Cantargia AB |
Mentice to Acquire Eqip and MyIRlog(TM) |
STOCKHOLM, Oct. 8, 2020 /PRNewswire/ -- Mentice AB (STO: MNTC) today signed an agreement to acquire all assets of the Jacksonville, Florida based MedTech company Eqip, Inc., a health IT cloud services and data analytics startup. Read more ›› |
By: PR Newswire Association LLC. - 08 Oct 2020 |
Related companies: Mentice AB |
AlzeCure gets abstract on the Alzstatin platform against Alzheimer's accepted for poster presentation at CTAD |
STOCKHOLM, Oct. 8, 2020 /PRNewswire/ -- AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of drug candidates for diseases affecting the central nervous system, with projects in both Alzheimer's disease and pain, today announced that the company... Read more ›› |
By: PR Newswire Association LLC. - 08 Oct 2020 |
Related companies: AlzeCure Pharma AB |
AnaConDa from Sedana Medical reviewed by NICE in UK |
STOCKHOLM, Oct. 7, 2020 /PRNewswire/ -- Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced that the UK's National Institute for Health and Care Excellence (NICE) has issued a Medtech innovation briefing (MIB) on the use of AnaConDa as an alternative to intravenous... Read more ›› |
By: PR Newswire Association LLC. - 07 Oct 2020 |
Related companies: Sedana Medical AB (publ) |
ColdZyme launched in Israel |
STOCKHOLM, Oct. 7, 2020 /PRNewswire/ -- Enzymatica's cold spray ColdZyme® has now been launched in Israel by Chemipal - a leading pharmaceutical distributor in the country. Chemipal will carry out an extensive marketing campaign for ColdZyme involving advertising, radio commercials, digital... Read more ›› |
By: PR Newswire Association LLC. - 07 Oct 2020 |
Related companies: Enzymatica AB |
« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 » |
Upcoming Life Sciences Events
- January 2021
- BioSeed Digital 2021
- NutrEvent
- AgeingFIT